Literature DB >> 590299

Angina pectoris in presumably healthy middle-aged men. Validation of two questionnaire methods in making the diagnosis of angina pectoris.

J Erikssen, K Forfang, O Storstein.   

Abstract

In 2014 presumably healthy men aged 40-59 yr the prevalence of previously undiagnosed angina pectoris was assessed by two angina questionnaires: (1) World Health Organization Questionnaire (WHO-Q) and (2) Greater New York Health Insurance Plan Survey Questionnaire (NY-Q). The angina prevalence given by the questionnaires singly or in combination varied between 1.15 and 4.7% (lowest prevalence by the WHO-Q interview version (WHO-Qi) and highest by the WHO-Q self-administered version and the NY-Q in combination), indicating a considerable variation in prevalence with variation in criteria used. Validation of the questionnaires by means of (1) coronary angiography, and (2) follow-up in selected cases, indicated NY-Q superiority over WHO-Q in predicting the presence of coronary heart disease (CHD). WHO-Qi had a particularly low sensitivity without being more specific. However, CHD-risk factor patterns in subgroups of individuals classified as angina-positive or -negative by the respective questionnaires were similar.

Entities:  

Mesh:

Year:  1977        PMID: 590299

Source DB:  PubMed          Journal:  Eur J Cardiol        ISSN: 0301-4711


  2 in total

1.  Rose Angina Questionnaire: validation with cardiologists' diagnoses to detect coronary heart disease in Bangladesh.

Authors:  Muhammad Aziz Rahman; Nicola Spurrier; Mohammad Afzal Mahmood; Mahmudur Rahman; Sohel Reza Choudhury; Stephen Leeder
Journal:  Indian Heart J       Date:  2012-09-12

2.  Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization.

Authors:  Wai Man Wong; Kwok Fai Lam; Cecilia Cheng; Wai Mo Hui; Harry Hua-Xiang Xia; Kam Chuen Lai; Wayne H C Hu; Jia Qing Huang; Cindy L K Lam; Chi Kuen Chan; Annie O O Chan; Shiu Kum Lam; Benjamin Chun-Yu Wong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.